Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v4-FR | Version v3-EN | |
---|---|---|
Language | French | English |
Date Updated | 2020-10-13 | 2020-10-13 |
Drug Identification Number | 02479494 | 02479494 |
Brand name | SANDOZ FLUOXETINE | SANDOZ FLUOXETINE |
Common or Proper name | SANDOZ FLUOXETINE | SANDOZ FLUOXETINE |
Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
Ingredients | FLUOXETINE | FLUOXETINE |
Strength(s) | 20MG | 20MG |
Dosage form(s) | CAPSULE | CAPSULE |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | 100HGC BO V1 CA | 100HGC BO V1 CA |
ATC code | N06AB | N06AB |
ATC description | ANTIDEPRESSANTS | ANTIDEPRESSANTS |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2020-10-02 | 2020-10-02 |
Estimated end date | 2020-10-09 | 2020-10-09 |
Actual end date | 2020-10-09 | 2020-10-09 |
Shortage status | Resolved | Resolved |
Tier 3 Status | No | No |
Company comments | Delay in the release of the drug | Delay in the release of the drug |
Health Canada comments |